Rasph

Avatar Medical and the EIC Accelerator: Scans in 3D for Surgeons

September 30, 2026864 words5 min

Avatar Medical, founded in Paris in 2020, makes software that converts CT and MRI scans into interactive, photorealistic 3D models for surgeons and patients. Its EIC project described "the first photorealistic XR viewer of 3D medical images", with cloud rendering and clinical applications for orthopaedic, cancer and vascular surgery, promising hospitals productivity gains "without investing in new equipment or personnel", according to CORDIS.

The European Innovation Council granted €2,492,262 towards a €3.56 million project from June 2023 to August 2025. The report says the company completed a shoulder replacement planning platform, "brAIn Shoulder Positioning", which won FDA clearance and "is now commercialized in the USA through a partnership with the Medtech implant manufacturer FX Shoulder", built a cloud architecture for demanding volume rendering, and developed a way to run its viewer over hospital networks. In April 2026 its main product, Avatar Medical Vision, received FDA 510(k) clearance, which the company says makes it the first software cleared for glasses-free 3D medical displays.

€2.49MEIC grant, 70% of a €3.56M project
2FDA-cleared products
20+Hospitals worked with, per company
Not publicRevenue

Company file

Legal entity
Avatar Medical SAS, SIREN 885 007 112, Paris
Founded
4 July 2020
Products
Avatar Medical Vision (CE-marked, FDA-cleared); brAIn Shoulder Positioning
Partners
FX Shoulder, Barco, Kyber
Hospital users
University of Miami Health System, Institut Curie
EIC project
AVATAR, 1 Jun 2023 to 31 Aug 2025, closed
EIC funding
Grant first

Where Avatar Medical Stands Now

In June 2026 the University of Miami Health System began deploying Eonis Vision, Avatar's software on Barco's glasses-free 3D display, in neurosurgery consultations, the first clinical installation. The Institut Curie in Paris has equipped its surgeons and radiologists with the software, according to the company's news page. In September 2026 Avatar Medical and Kyber were awarded up to €3.7 million under France 2030 to stream immersive 3D imaging anywhere in a hospital.

"We have fully completed the design, development, testing and certification (FDA clearance obtained, CE mark pending) of a software platform dedicated to shoulder arthroplasty."

Avatar Medical, report to the EIC

The Technology: Seeing Anatomy Without Segmentation

Surgeons usually rely on 2D slices or simplified 3D reconstructions that lack soft tissue and vessels, the report says. Avatar's volume rendering shows full-detail 3D anatomy that can be adjusted in real time, highlighting or hiding organs, without manual segmentation. It works on standard screens, VR headsets and autostereoscopic displays, and the company says it also helps explain procedures to patients.

What the EIC Project Promised, and What CORDIS Shows

The project promised an XR viewer with cloud rendering and clinical applications for surgery. The report documents a commercialised shoulder planning product, cloud rendering and network distribution of the viewer, plus components for future products. Subsequent FDA clearance of the core viewer confirms the platform matured. CORDIS lists the project as closed.

  1. Clinical applicationDeliveredShoulder planner, FDA.
  2. Cloud renderingDeliveredPer report.
  3. XR viewer in hospitalsDeliveredMiami, Curie.
  4. Commercial scaleUnverifiedRevenue not published.

The Money

Avatar Medical has not published its accounts; the French register shows 10 to 19 employees in 2022 and no financial summary, according to Pappers. The EIC award was grant first, and no EIC Fund investment has been announced. Its latest public funding is the France 2030 award shared with Kyber.

What Cannot Be Checked

Questions for the EIC

How much Avatar Medical earns, how many hospitals pay for its software, whether it has raised private equity and how much of the France 2030 award it receives are not public.

Why Europe Should Care

Clearer images can lead to less invasive surgery, the report argues, and help patients understand their operations. The EIC funded a Paris company that now has US clearances and partners such as Barco and FX Shoulder. Its business scale remains private.

What the project promised

The first photorealistic XR viewer of 3D medical images, with clinical applications for surgeons.

What the record shows

Two FDA-cleared products, hospital deployments and new public funding, with revenue undisclosed.

The Verdict

Delivered and cleared

Avatar Medical did what the EIC paid for and took its software through the FDA. How far sales have followed is the open question.

Avatar Medical and the EIC have not been asked for comment for this article. It is based entirely on public records and published statements, linked throughout.

Start with the EIC Accelerator

Professional proposal writing and expert review for Step 1 and Step 2.

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges is a new pilot program offering €300,000 (Stage 1) and up to €2.5 million (Stage 2) for breakthrough deep-tech solutions through ARPA-style staged funding with demand-side integration. The program targets single entities or small consortia (2-3 partners) including SMEs, start-ups, and research organizations. Focus areas include Physical AI for autonomous robotics and New Approach Methodologies (NAMs) for animal-free biomedical testing, requiring TRL 4 entry with end-user commitment.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
EIC AcceleratorBeneficiary Deep Dive#Avatar Medical#medical imaging#virtual reality#surgery#software#France
Loading